Literature DB >> 24627613

Chronic total artery occlusions in noninfarct-related coronary arteries.

Ozcan Ozeke1, Mutlu Gungor2, Serkan Topaloglu1, Dursun Aras1, Can Ozer2.   

Abstract

It has been rarely encountered some patients in clinical practice with coronary artery chronic total occlusion (CTO) on angiography but no any clinical history or electrocardiographic, echocardiographic, or left ventriculographic evidence of previous myocardial infarction. These noninfarct-related artery CTO (non-IRA CTO) lesions may be used as a clinical role model of endogenous cardioprotective mechanisms in addition to continuing the process of atherosclerosis. The objective of this study was to characterize the clinical characteristics of patients with non-IRA CTO patients and compared them to those with infarct-related CTO (IRA-CTO). We reviewed our invasive cardiology database searching for the CTO of any major coronary arteries, and assessed whether or not they have the clinical history or electrocardiographic, echocardiographic, and left ventriculographic evidence of previous myocardial infarction. Interestingly, we detected that all these patients with non-IRA CTO had diabetes mellitus, and the clinical and demographic features of these non-IRA CTO patients were compared with age- and sex-matched diabetic IRA-CTO patients with regard to conventional coronary risk factors and the angiographic collateral grading system. There were total 99 CTO patients (49 patients with non-IRA CTO and 50 patients with IRA-CTO).All patients with non-IRA CTO had better collateral circulation (96 vs. 40% p < 0.001) compared with those having IRA-CTO. The only significant difference between the groups was the status of current smoking (4 vs. 88%; p < 0.001). The present study showed that the non-IRA CTOs were associated with diabetes mellitus and better collateral development compared with IRA-CTO. In diabetic patients, the concomitant smoking use may be harmful by preventing endogenous cardioprotective mechanisms.

Entities:  

Keywords:  cardioprotection; chronic total coronary occlusion; diabetes

Year:  2014        PMID: 24627613      PMCID: PMC3933498          DOI: 10.1055/s-0033-1356648

Source DB:  PubMed          Journal:  Int J Angiol        ISSN: 1061-1711


  35 in total

1.  Angiogenesis and arteriogenesis--not yet for prescription.

Authors:  A Helisch; W Schaper
Journal:  Z Kardiol       Date:  2000-03

Review 2.  Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions.

Authors:  R Virmani; F D Kolodgie; A P Burke; A Farb; S M Schwartz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-05       Impact factor: 8.311

Review 3.  The pathophysiology of the collateral circulation (arteriogenesis).

Authors:  I Buschmann; W Schaper
Journal:  J Pathol       Date:  2000-02       Impact factor: 7.996

4.  Effect of diabetes mellitus on formation of coronary collateral vessels.

Authors:  A Abaci; A Oğuzhan; S Kahraman; N K Eryol; S Unal; H Arinç; A Ergin
Journal:  Circulation       Date:  1999-05-04       Impact factor: 29.690

5.  Coronary collaterals in patients with normal and impaired left ventricular systolic function.

Authors:  R Ilia; S Carmel; C Cafri; M Gueron
Journal:  Int J Cardiol       Date:  1998-01-31       Impact factor: 4.164

6.  Effect of recanalization of chronic total occlusions on global and regional left ventricular function in patients with or without previous myocardial infarction.

Authors:  Chang-Min Chung; Shigeru Nakamura; Koji Tanaka; Jun Tanigawa; Katsuya Kitano; Tatsurou Akiyama; Yoshiki Matoba; Osamu Katoh
Journal:  Catheter Cardiovasc Interv       Date:  2003-11       Impact factor: 2.692

Review 7.  Why do we still not have cardioprotective drugs?

Authors:  James M Downey; Michael V Cohen
Journal:  Circ J       Date:  2009-06-09       Impact factor: 2.993

Review 8.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

Authors:  Morteza Naghavi; Peter Libby; Erling Falk; S Ward Casscells; Silvio Litovsky; John Rumberger; Juan Jose Badimon; Christodoulos Stefanadis; Pedro Moreno; Gerard Pasterkamp; Zahi Fayad; Peter H Stone; Sergio Waxman; Paolo Raggi; Mohammad Madjid; Alireza Zarrabi; Allen Burke; Chun Yuan; Peter J Fitzgerald; David S Siscovick; Chris L de Korte; Masanori Aikawa; K E Juhani Airaksinen; Gerd Assmann; Christoph R Becker; James H Chesebro; Andrew Farb; Zorina S Galis; Chris Jackson; Ik-Kyung Jang; Wolfgang Koenig; Robert A Lodder; Keith March; Jasenka Demirovic; Mohamad Navab; Silvia G Priori; Mark D Rekhter; Raymond Bahr; Scott M Grundy; Roxana Mehran; Antonio Colombo; Eric Boerwinkle; Christie Ballantyne; William Insull; Robert S Schwartz; Robert Vogel; Patrick W Serruys; Goran K Hansson; David P Faxon; Sanjay Kaul; Helmut Drexler; Philip Greenland; James E Muller; Renu Virmani; Paul M Ridker; Douglas P Zipes; Prediman K Shah; James T Willerson
Journal:  Circulation       Date:  2003-10-07       Impact factor: 29.690

9.  Paradoxical arterial wall shrinkage may contribute to luminal narrowing of human atherosclerotic femoral arteries.

Authors:  G Pasterkamp; P J Wensing; M J Post; B Hillen; W P Mali; C Borst
Journal:  Circulation       Date:  1995-03-01       Impact factor: 29.690

Review 10.  Collateral circulation: past and present.

Authors:  Wolfgang Schaper
Journal:  Basic Res Cardiol       Date:  2008-12-20       Impact factor: 17.165

View more
  2 in total

1.  Change in left ventricular systolic function in patients with ST elevation myocardial infarction: Evidence for smoker's paradox or pseudo-paradox?

Authors:  Burak Acar; Ozcan Ozeke; Sefa Unal; Mustafa Karakurt; Meryem Kara; Ozgur Kirbas; Fatih Sen; Ahmet Korkmaz; Dursun Aras; Sinan Aydogdu
Journal:  Indian Heart J       Date:  2016-04-14

Review 2.  Reduced coronary collateralization in type 2 diabetic patients with chronic total occlusion.

Authors:  Ying Shen; Feng Hua Ding; Yang Dai; Xiao Qun Wang; Rui Yan Zhang; Lin Lu; Wei Feng Shen
Journal:  Cardiovasc Diabetol       Date:  2018-02-08       Impact factor: 9.951

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.